Detalhe da pesquisa
1.
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).
J Clin Oncol
; 35(19): 2157-2164, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463633
2.
Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.
J Clin Oncol
; 31(13): 1624-30, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23547078